Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy
Authors:
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 29 references indexed in Scilit:
- Antiplatelet effects of aspirin vary with level of P2Y12 receptor blockade supplied by either ticagrelor or prasugrelJournal of Thrombosis and Haemostasis, 2011
- In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregationJournal of Thrombosis and Haemostasis, 2010
- Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary SyndromesJACC, 2010
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery DiseaseCirculation, 2009
- Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patientsThrombosis and Haemostasis, 2006
- Low-Dose Aspirin for the Prevention of AtherothrombosisNew England Journal of Medicine, 2005
- Effects of a Novel Platelet Nitric Oxide Donor (LA816), Aspirin, Clopidogrel, and Combined Therapy in Inhibiting Flow- and Lesion-Dependent Thrombosis in the Porcine Ex Vivo ModelCirculation, 2004
- Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparinJACC, 2004
- Clopidogrel for Coronary StentingCirculation, 2003
- Administration of Abciximab During Percutaneous Coronary Intervention Reduces Both Ex Vivo Platelet Thrombus Formation and Fibrin DepositionArteriosclerosis, Thrombosis, and Vascular Biology, 1998